Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for ...

Scientists have discovered that the brain’s short-range wiring may help protect cognition even as gray matter shrinks with ...

Pixclara is a radioactive diagnostic drug paired with PET imaging, used to help doctors distinguish between returning brain ...

RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint Meeting ...

The FDA has approved Pixclara (floretyrosine F 18), the first FET-PET imaging agent for distinguishing recurrent glioma from treatment-related change. The FDA has approved floretyrosine F 18 (18F-FET; ...

The United States Food and Drug Administration has approved Telix Pharmaceutical's Pixclara, an imaging agent to aid in the ...

Functional magnetic resonance imaging, or fMRI, gives researchers a powerful way to study brain activity. But the scans can ...

Researchers at Johns Hopkins Medicine have demonstrated a new approach to brain imaging that enables continuous monitoring of ...

Women's hormonal health, and particularly how hormones shape brain function, has long been a research blind spot. This study ...

<?xml encoding="utf-8" ?> On Monday, the U.S. Food and Drug Administration (FDA) approved Pixclara (floretyrosine F18), an ...

FDA approves Telix Pharmaceuticals’ Pixclara (FET-PET) for glioma imaging, helping distinguish recurrence from treatment ...